Actimed Therapeutics Strengthens Board with Appointment of Dr. Anders Ullman

Source Summary

London, UK – 30 July 2026. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, today announces the appointment of Dr. Anders Ullman to its Board of Directors.